Urology News and Research

Latest Urology News and Research

Doctors offer ways to help protect kidneys

The kidneys, two very important organs located in your back, help to continuously clean out wastes and extra fluid from your body. One in 10 Americans develops kidney disease due to diabetes, high blood pressure or a family history of kidney failure.

3 Mar 2014

Extract from amur cork tree shows promise in treating pancreatic cancer

The bark of the Amur cork tree (Phellodendron amurense) has traveled a centuries-long road with the healing arts. Now it is being put through its paces by science in the fight against pancreatic cancer, with the potential to make inroads against several more.

3 Mar 2014

Actavis files ANDA with FDA to market Colchicine Tablets USP

Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Colchicine Tablets USP, 0.6 mg.

3 Mar 2014

Vétoquinol acquires Bioniche's Animal Health business

Vétoquinol (NYSE Euronext Paris: VETO) and Bioniche Life Sciences Inc. (TSX: BNC), today jointly announced their signing of a share purchase agreement under which Vétoquinol has agreed to purchase Bioniche's Animal Health business for the cash purchase price of CAD$61 million.

28 Feb 2014

NAFC designates Beth Israel Deaconess Medical Center as Center of Excellence

The National Association For Continence has designated Beth Israel Deaconess Medical Center as a Center of Excellence: Continence Care. Anurag K. Das, MD; Roger Lefevre, MD; Janet Li, MD; and Deborah A. Nagle, MD are the principle physicians for this COE.

27 Feb 2014

Survival rates for bladder cancer in UK are falling, confirms new study

Of the top 10 cancers in the UK, bladder cancer is only one where survival rates have been shown to be getting worse. New figures published this month in the Journal of Clinical Urology confirm in a study of cases of bladder cancer in England over a 19 year period (from 1990 until 2009) that survival rates here in the UK are falling and are worse than in than in other European countries with similar incidence rates.

27 Feb 2014

Study: Patients more likely to die in hospitals when cared for by nurses with heavy workloads

Patients are more likely to die after common surgical procedures when they are cared for in hospitals with heavier nurse workloads and fewer nurses with bachelor's degrees, concludes the largest investigation of nursing and hospital outcomes in Europe to date, published in The Lancet.

26 Feb 2014

Robotic-assisted radical prostatectomy shows better outcomes in cancer removal

An observational study from UCLA's Jonsson Comprehensive Cancer comparing robotic-assisted prostate surgery to open surgery for prostate cancer found that patients who had robotic surgery had fewer instances of cancer cells at the edge of the surgical specimen, or fewer positive margins, and less need of additional cancer treatments, such as hormone therapy or radiation, than patients who had open surgery.

26 Feb 2014

Detrusor muscle function declines with age

Detrusor muscle function and efficiency decline with increasing age, a urodynamic study of women with stress urinary incontinence indicates.

25 Feb 2014

Research could lead to early diagnosis and treatment of prostate cancer

Prostate cancer patients could get better diagnosis and treatment for the disease in the future thanks to a successful research project at the University of Essex.

25 Feb 2014

Blocking mechanisms for DNA repair may help to potentiate chemotherapy, says study

Chemotherapies are cancer treatments that work by inducing lesions in the DNA of tumour cells in order to inhibit their proliferation. However, the body naturally tries to repair these lesions, and thus reduces the efficacy of chemotherapy.

24 Feb 2014

Hu-Friedy, EMS partner to deliver clinically advanced prophylaxis protocol to U.S. and Canadian markets

Hu-Friedy, a global leader in the manufacturing of dental instruments and products, and Switzerland-based Electro Medical Systems today announced a strategic alliance to deliver the most clinically advanced prophylaxis protocol to the U.S. and Canadian markets by leveraging Hu-Friedy's heritage in high-quality hand instrumentation, coupled with best-in-class EMS offerings in Piezo power scaling and air polishing.

20 Feb 2014

Syneron Medical enters into agreement to acquire New Star Lasers

Syneron Medical Ltd., the leading global aesthetic device company, announced today that it has entered into an agreement to acquire New Star Lasers, Inc., which conducts business as CoolTouch, Inc., for approximately $11 million in cash and earn out based on certain milestones of up to $4 million until end of 2015.

20 Feb 2014

Certain fragments of DNA shed by tumors can be used to non-invasively screen for early-stage cancers

Certain fragments of DNA shed by tumors into the bloodstream can potentially be used to non-invasively screen for early-stage cancers, monitor responses to treatment and help explain why some cancers are resistant to therapies, according to results of an international study led by Johns Hopkins Kimmel Cancer Center investigators.

20 Feb 2014

Mauna Kea installs flagship Cellvizio system at Apollo Gleneagles Hospital in Kolkata

Mauna Kea Technologies (Paris:MKEA) (Euronext: MKEA, FR0010609263), leader in the optical biopsy market, announced today it has installed its flagship Cellvizio system at the Apollo Gleneagles Hospital in Kolkata, a leading center of excellence in Gastroenterology in India, part of the Apollo Hospitals Group.

20 Feb 2014

NIH-funded session in Bethesda to heighten awareness of underactive bladder

Underactive bladder, estimated to affect more than 20 percent of the elderly population, is an unrecognized disease that has a major influence on the health and independence of seniors.

20 Feb 2014

Matching the right tumor with the right drug

There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.

19 Feb 2014

Phasefocus’ KTP associate Dr Suman receives runners up spot for Cellular Heaven and Hell time-lapse video

Phase Focus Ltd (Phasefocus), the company that is revolutionizing microscopy and imaging with the Phasefocus Virtual Lens® technology, reports on the Celldance competition results held at the recent annual ASCB meeting. KTP associate, Dr Rakesh Suman, was runner up with his video entitled "Cellular Heaven & Hell."

From Phase Focus Limited 18 Feb 2014

Sanford Health opens new clinic in Dickinson, ND

The new Sanford Health Dickinson Clinic, which is replacing the existing Sanford Health Dickinson Clinic, is now open. The new clinic, located at 2615 Fairway St., is more than six times the size of the current clinic at 938 Second Ave. W. and can house more than 20 physicians, providing better patient access than ever before.

18 Feb 2014

New score ‘reliable and valid’ for neurogenic bladder dysfunction

The Neurogenic Bladder Symptom Score is both valid and reliable for assessing urinary dysfunction in people with acquired or congenital neurogenic bladder, according to a study published online in the Journal of Urology.

17 Feb 2014